Mefren may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Mefren in the following countries:
Chlorhexidine dihydrochloride (a derivative of Chlorhexidine) is reported as an ingredient of Mefren in the following countries:
International Drug Name Search
ol-me-SAR-tan me-DOX-oh-mil
Drugs that act directly on the renin-angiotensin system can cause injury or death to the developing fetus when used during the second and third trimesters. Stop therapy as soon as possible when pregnancy is detected .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Cardiovascular Agent
Pharmacologic Class: Angiotensin II Receptor Antagonist
Olmesartan is used alone or together with other medicines to treat high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure also may increase the risk of heart attacks. These problems may be less likely to occur if blood pressure is controlled.
Olmesartan is an angiotensin II receptor blocker. It works by blocking a substance in the body that causes blood vessels to tighten. As a result, olmesartan relaxes blood vessels. This lowers blood pressure and increases the supply of blood and oxygen to the heart.
olmesartan medoxomil is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For olmesartan medoxomil, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to olmesartan medoxomil or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of olmesartan in children.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of olmesartan in the elderly.
| Pregnancy Category | Explanation | |
|---|---|---|
| 1st Trimester | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
| 2nd Trimester | D | Studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk. |
| 3rd Trimester | D | Studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking olmesartan medoxomil, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using olmesartan medoxomil with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using olmesartan medoxomil with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of olmesartan medoxomil. Make sure you tell your doctor if you have any other medical problems, especially:
Take olmesartan medoxomil only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.
In addition to taking olmesartan medoxomil, treatment for your high blood pressure may include weight control and a change in the foods you eat, especially foods high in sodium (salt). Your doctor will tell you which of these are most important for you. You should check with your doctor before changing your diet.
Many patients who have high blood pressure will not notice any signs of the problem. In fact, many may feel normal. It is very important that you take your medicine exactly as directed and that you keep your appointments with your doctor even if you feel well.
Remember that olmesartan medoxomil will not cure your high blood pressure, but it does help control it. You must continue to take it as directed if you expect to lower your blood pressure and keep it down. You might have to take high blood pressure medicine for the rest of your life. If high blood pressure is not treated, it can cause serious problems such as heart failure, blood vessel disease, stroke, or kidney disease.
olmesartan medoxomil may be taken with or without food.
The dose of olmesartan medoxomil will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of olmesartan medoxomil. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of olmesartan medoxomil, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check the progress of you or your child at regular visits to make sure olmesartan medoxomil is working properly. Blood tests may be needed to check for unwanted effects.
Using olmesartan medoxomil while you are pregnant can harm your unborn baby. If you think you have become pregnant while using olmesartan medoxomil, tell your doctor right away.
Dizziness or lightheadedness may occur after the first dose of olmesartan medoxomil, especially if you have been taking a diuretic (water pill). Make sure you know how you react to olmesartan medoxomil before you drive, use machines, or do anything else that could be dangerous if you are dizzy.
Check with your doctor right away if you or your child become sick while taking olmesartan medoxomil, especially with severe or continuing nausea, vomiting, or diarrhea. These conditions may cause you to lose too much water, which can lead to low blood pressure.
Dizziness, lightheadedness, or fainting may also occur if you or your child exercise or if the weather is hot. Heavy sweating may cause you to lose too much water or salt, which may cause low blood pressure. Use extra care during exercise or hot weather.
Do not take other medicines unless they have been discussed with your doctor. This especially includes over-the-counter (nonprescription) medicines for appetite control, asthma, colds, cough, hay fever, or sinus problems, since they may tend to increase your blood pressure.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Get emergency help immediately if any of the following symptoms of overdose occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: olmesartan medoxomil side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Class: Antitussives
ATC Class: R05DB01
VA Class: RE302
CAS Number: 104-31-4
Brands: Tessalon
Special Alerts:
[Posted 12/14/2010] ISSUE: FDA is warning the public that accidental ingestion of benzonatate (Tessalon) by children under the age of 10 years can result in death from overdose. Overdose with benzonatate in children less than 2 years of age has been reported following accidental ingestion of as few as 1 or 2 capsules. Benzonatate may be attractive to children because of the drug's appearance (it is a round-shaped liquid-filled gelatin capsule).
BACKGROUND: Benzonatate is a prescription drug approved for relief of cough in patients over 10 years of age. The safety and effectiveness of benzonatate in children under 10 years of age have not been established. Benzonatate is sold under the brand-name Tessalon and is also sold in generic preparations. Individuals who experience overdose of benzonatate may exhibit restlessness, tremors, convulsions, coma, and cardiac arrest. Signs and symptoms of overdose can occur rapidly after ingestion (within 15-20 minutes). Deaths in children have been reported within hours of the accidental ingestion.
RECOMMENDATION: Patients who are taking benzonatate should keep the medication in a child-resistant container and store it out of reach of children. If a child accidentally ingests benzonatate, seek medical attention immediately. Signs and symptoms of benzonatate overdose can occur rapidly after ingestion (within 15-20 minutes) and may include restlessness, tremors, convulsions, coma, and cardiac arrest. For more information visit the FDA website at: and .
Local anesthetic antitussive agent.a b
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Used for symptomatic relief of cough.100 101 106 108
May be effective in suppressing cough in acute respiratory conditions such as pneumonia, bronchitis, pertussis, and the common cold; and in chronic diseases such as pulmonary emphysema, bronchial asthma, tuberculosis, and pulmonary tumor.b
Has been shown to be more effective than codeine in reducing the frequency of experimentally induced cough,101 and may be effective in providing symptomatic relief in patients with opiate-resistant cough.108
Has been applied locally in the oral cavity in adults by releasing the drug from the liquid-filled capsules (e.g., by chewing or dissolving two 100-mg liquid-filled capsules in the mouth) to provide sufficient oropharyngeal anesthesia for conscious intubation†.107
Do not employ this method of administration† when the drug is used as an antitussive because of the risk of potentially life-threatening complications resulting from local effects on the oropharyngeal tract.100 101 102 104 (See Sensitivity Reactions under Cautions and also Oral Administration under Dosage and Administration.)
Swallow the liquid-filled capsules whole.100 101 102
Do not chew or dissolve in the mouth when used as an antitussive, since temporary, potentially life-threatening local anesthesia of the oral mucosa, choking, or severe hypersensitivity reactions could occur; oropharyngeal anesthesia develops rapidly with such improper administration.100 101 102
Local administration† (chewing the capsules or allowing to dissolve in mouth) can be employed to facilitate conscious intubation†.103 107 (See Conscious Intubation under Uses.)
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Children ≤10 years of age: 8 mg/kg daily in 3–6 divided doses†,106 although safety and efficacy have not been established in this age group.100 (See Pediatric Use under Cautions.)
Children >10 years of age: 100 or 200 mg 3 times daily.100 101 106
100 or 200 mg 3 times daily;100 101 106 doses up to 600 mg daily may be given in divided doses if necessary.100 101 106
Children >10 years of age: Maximum 600 mg daily in divided doses.100 101 106
Maximum 600 mg daily in divided doses.100 101 106
No specific dosage recommendations for hepatic impairment.a b
No specific dosage recommendations for renal impairment.a b
No specific geriatric dosage recommendations.a
Known hypersensitivity to the drug or related compounds.100
Severe hypersensitivity reactions, including bronchospasm, laryngospasm, and cardiovascular collapse, have been reported with benzonatate.100 101 102
Such reactions may have resulted from local anesthesia secondary to sucking or chewing the liquid-filled capsules rather than swallowing them whole.100 101
Severe reactions have required medical intervention with vasopressor therapy and supportive measures.100
Deliberate or accidental overdosage of benzonatate can result in CNS stimulation which may lead to restlessness, tremors, and seizures; profound CNS depression and death can follow.100 103 104 105
Dizziness,104 disorientation,103 drunken feeling,104 unresponsiveness,104 pulmonary congestion,104 ventricular tachycardia,103 cardiac arrest,103 and nausea104 also have been reported with overdosage.
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Rarely, bizarre behavior, including mental confusion and visual hallucinations, when used concomitantly with certain other drugs.100
Possibility that adverse CNS effects associated with other p-aminobenzoic acid-derivative local anesthetics (e.g., procaine, tetracaine) could occur with benzonatate should be considered.100
Category C.a
Not known whether benzonatate is distributed into milk.100 Caution if used in nursing women.100
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Risk of overdosage and toxicity (including death) in children <2 years of age receiving OTC preparations containing antihistamines, cough suppressants, expectorants, and nasal decongestants alone or in combination for relief of symptoms of upper respiratory tract infection.109 110 Limited evidence of efficacy for these preparations in this age group; appropriate dosages not established.109 Therefore, FDA recommends not to use such preparations in children <2 years of age; safety and efficacy in older children currently under evaluation. Because children 2–3 years of age also are at increased risk of overdosage and toxicity, some manufacturers of oral nonprescription cough and cold preparations recently agreed to voluntarily revise the product labeling to state that such preparations should not be used in children <4 years of age. During the transition period, some preparations on pharmacy shelves will have the new recommendation (“do not use in children <4 years of age”), while others will have the previous recommendation (“do not use in children <2 years of age”). FDA recommends that parents and caregivers adhere to dosage instructions and warnings on the product labeling that accompanies the preparation and consult a clinician about any concerns. Clinicians should ask caregivers about use of OTC cough/cold preparations to avoid overdosage.
Generally well tolerated when the liquid-filled capsules are swallowed intact.100 101 106
Adverse effects may include sedation, headache, mild dizziness, bizarre behavior (e.g., mental confusion, visual hallucinations), nasal congestion, nausea, GI upset, constipation, sensation of burning in the eyes, a vague “chilly” sensation, pruritus and skin eruptions, numbness in the chest, and hypersensitivity (e.g., bronchospasm, laryngospasm, cardiovascular collapse, possibly related to local anesthesia from chewing or sucking the liquid-filled capsules).100 103 106 (See Sensitivity Reactions under Cautions.)
Usually within 15–20 minutes after swallowing capsules intact.100 103 104 106
Oropharyngeal anesthesia: Develops rapidly when applied locally (e.g., by chewing or dissolving the liquid-filled capsules in the mouth),100 101 102 104 107 with complete anesthesia occurring within about 1 minute.107
Approximately 3–8 hours following a single oral dose.100 101 103 104 106
Tight, light-resistant containers at 15–30°C.100
Inhibits cough production by anesthetizing stretch receptors of vagal afferent fibers in the bronchi, alveoli, and pleura that mediate the cough reflex; also suppresses transmission of the cough reflex at the level of the medulla where the afferent impulse is transmitted to the motor nerves.b
Does not depress respiration at recommended dosages100 104 106 ; in patients with bronchial asthma, the drug has been reported to increase the rate and depth of respiration, minute volume, and vital capacity.b
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Importance of warning patients using benzonatate as an antitussive to swallow the liquid-filled capsules whole without chewing or dissolving in the mouth because of risk of potentially life-threatening local anesthesia.b (See Oral Administration under Dosage and Administration and also Sensitivity Reactions under Cautions.)
Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs as well as any concomitant illnesses.
Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.100
Importance of informing patients of other important precautionary information.100 (See Cautions.)
Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
|---|---|---|---|---|
Oral | Capsules, liquid-filled | 100 mg* | Tessalon Perles (with parabens) | Forest |
200 mg | Tessalon Capsules (with gelatin, glycerin, and parabens) | Forest |
This pricing information is subject to change at the sole discretion of DS Pharmacy. This pricing information was updated 03/2011. Actual costs to patients will vary depending on the use of specific retail or mail-order locations and health insurance copays.
Benzonatate 100MG Capsules (ASCEND LABORATORIES): 30/$19.99 or 60/$29.98
Benzonatate 200MG Capsules (ZYDUS PHARMACEUTICALS (USA)): 30/$33.99 or 90/$89.98
Tessalon Perles 100MG Capsules (PFIZER U.S.): 30/$49.99 or 90/$139.97
This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.
The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.
AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions January 2011. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.
† Use is not currently included in the labeling approved by the US Food and Drug Administration.
100. Forest Pharmaceuticals. Tessalon (benzonatate) prescribing information (dated 1999 Aug). In: Physicians’ desk reference. 55th ed. Montvale, NJ: Medical Economics Company Inc; 2001:1270.
101. Food and Drug Administration. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; tentative final monograph for OTC antitussive drug products. Proposed rule. [21 CFR Part 341] Fed Regist. 1983; 48:48576-95. (lDIS 176844)
102. Food and Drug Administration. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; tentative final monograph for OTC antitussive drug products. Final rule. [21 CFR Part 310,341,369] Fed Regist. 1987; 52:30042-7. (lDIS 232963)
103. Crouch BI, Knick KA, Crouch DJ et al. Benzonatate overdose associated with seizures and arrhythmias. J Toxicol Clin Toxicol. 1998; 36:713-8. [IDIS 420898] [PubMed 9865240]
104. Cohan JA, Conradi SE. Two fatalities resulting from Tessalon (benzonatate). Vet Human Toxicol. 1986; 28:543-4.
105. Sheen S, Osterhoudt K, Birenbaum D. Seizures in a toddler associated with benzonatate ingestion. J Toxicol Clin Toxicol. 1997; 35:493.
106. Anon. Benzonatate. In: Osol A, Pratt R, eds. The United States dispensatory. Philadelphia: JB Lippincott Company; 1973:187-8.
107. Mongan PD, Culling RD. Rapid oral anesthesia for awake intubation. J Clin Anesth. 1992; 4:101-5. [PubMed 1562332]
108. Doona M, Walsh D. Benzonatate for opioid-resistant cough in advanced cancer. Palliat Med. 1998; 12:55-8. [PubMed 9616460]
109. Srinivasan A, Budnitz D, Shehab N et al. Infant deaths associated with cough and cold medications—two states, 2005. MMWR Morb Mortal Wkly Rep. 2007; 56:1-4. [PubMed 17218934]
110. Food and Drug Administration. Cough and cold medications in children less than two years of age. Rockville, MD; 2007 Jan 12. From FDA website.
a. Forest Pharmaceuticals, Inc. Tessalon (benzonatate, USP) prescribing information. Schaumburg, IL: 2000 Sep.
b. AHFS drug information 2004. McEvoy GK, ed. Benzonatate. Bethesda, MD: American Society of Health-System Pharmacists; 2004:2596.
pdh. Schilling McCann JA, Publisher. Pharmacists drug handbook. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins and American Society of Health-System Pharmacists; 2003.
HID. Trissel LA. Handbook on injectable drugs. 12th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2003:175-80.
Flusolv may be available in the countries listed below.
Heparin calcium salt (a derivative of Heparin) is reported as an ingredient of Flusolv in the following countries:
International Drug Name Search
Intenacin may be available in the countries listed below.
Indometacin is reported as an ingredient of Intenacin in the following countries:
International Drug Name Search
See also: Generic Ritalin, Generic Ritalin-SR
Ritalin LA is a brand name of methylphenidate, approved by the FDA in the following formulation(s):
A generic version of Ritalin LA has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ritalin LA and have been approved by the FDA:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ritalin LA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Seronip may be available in the countries listed below.
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Seronip in the following countries:
International Drug Name Search
Rec.INN
D07AB21
0004828-27-7
C22-H28-Cl-F-O4
410
Dermatological agent
Adrenal cortex hormone, glucocorticoid
9-Chloro-6α-fluoro-11ß,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione (WHO)
Pregna-1,4-diene-3,20-dione, 9-chloro-6-fluoro-11,21-dihydroxy-16-methyl-, (6α,11ß,16α)-
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Rinosedin may be available in the countries listed below.
Xylometazoline hydrochloride (a derivative of Xylometazoline) is reported as an ingredient of Rinosedin in the following countries:
International Drug Name Search
Cisplat may be available in the countries listed below.
Cisplatin is reported as an ingredient of Cisplat in the following countries:
International Drug Name Search
Nafacil may be available in the countries listed below.
Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Nafacil in the following countries:
International Drug Name Search
Dacarbacina may be available in the countries listed below.
Dacarbazine is reported as an ingredient of Dacarbacina in the following countries:
International Drug Name Search
Eumacid may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Cloxacillin sodium salt (a derivative of Cloxacillin) is reported as an ingredient of Eumacid in the following countries:
International Drug Name Search
Naprogesic may be available in the countries listed below.
Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Naprogesic in the following countries:
International Drug Name Search
Trikozol may be available in the countries listed below.
Metronidazole is reported as an ingredient of Trikozol in the following countries:
International Drug Name Search
Amoxicillin axcount may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillin axcount in the following countries:
International Drug Name Search
Piracetam EG may be available in the countries listed below.
Piracetam is reported as an ingredient of Piracetam EG in the following countries:
International Drug Name Search
Orabiot may be available in the countries listed below.
Bromhexine is reported as an ingredient of Orabiot in the following countries:
International Drug Name Search
Denispan may be available in the countries listed below.
Distigmine Bromide is reported as an ingredient of Denispan in the following countries:
International Drug Name Search
Telset may be available in the countries listed below.
Tioconazole is reported as an ingredient of Telset in the following countries:
International Drug Name Search
Lisinopril Apotex Pharma may be available in the countries listed below.
Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril Apotex Pharma in the following countries:
International Drug Name Search
Ciplon may be available in the countries listed below.
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciplon in the following countries:
International Drug Name Search
Compound Magnesium may be available in the countries listed below.
Magnesium mixture of several salts (a derivative of Magnesium) is reported as an ingredient of Compound Magnesium in the following countries:
International Drug Name Search
Combination may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Fenbendazole is reported as an ingredient of Combination in the following countries:
Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Combination in the following countries:
International Drug Name Search
Cutaclin may be available in the countries listed below.
Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Cutaclin in the following countries:
International Drug Name Search
Fulkazil may be available in the countries listed below.
Fluconazole is reported as an ingredient of Fulkazil in the following countries:
International Drug Name Search
Cetriaf may be available in the countries listed below.
Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Cetriaf in the following countries:
International Drug Name Search
Ziloxican may be available in the countries listed below.
Meloxicam is reported as an ingredient of Ziloxican in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Solaquin (hydroquinone topical) is a member of the drug class topical depigmenting agents and is used to treat Dermatological Disorders.
US matches:
Hydroquinone is reported as an ingredient of Solaquin in the following countries:
Sulfaquinoxaline is reported as an ingredient of Solaquin in the following countries:
International Drug Name Search
Pymesezipam may be available in the countries listed below.
Diazepam is reported as an ingredient of Pymesezipam in the following countries:
International Drug Name Search
Quinapril/Hydrochlorothiazide Wyvern may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Quinapril/Hydrochlorothiazide Wyvern in the following countries:
Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Quinapril/Hydrochlorothiazide Wyvern in the following countries:
International Drug Name Search
Ariprazole may be available in the countries listed below.
Aripiprazole is reported as an ingredient of Ariprazole in the following countries:
International Drug Name Search
Dexaflam may be available in the countries listed below.
Dexamethasone is reported as an ingredient of Dexaflam in the following countries:
Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Dexaflam in the following countries:
International Drug Name Search
Micostat 7 may be available in the countries listed below.
Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Micostat 7 in the following countries:
International Drug Name Search
Selvénium may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Sodium Selenite is reported as an ingredient of Selvénium in the following countries:
Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Selvénium in the following countries:
International Drug Name Search
Cetirizin PCD may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizin PCD in the following countries:
International Drug Name Search
Dietary management of age-related macular degeneration in certain patients. It should only be used under the direction and supervision of a doctor.
Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin is a medical food. It works by providing vitamins to meet nutritional requirements.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin. However, no specific interactions with Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin are known at this time.
Ask your health care provider if Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea, nausea, stomach upset, or cramping; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store in original packaging until just before use. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Beta Carotene/Ascorbic Acid (Vitamin C)/Vitamin E/Zinc/Copper/Lutein/Zeaxanthin. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Sapropterin Dihydrochloride may be available in the countries listed below.
Sapropterin Dihydrochloride (USAN) is known as Sapropterin in the US.
International Drug Name Search
Glossary
| USAN | United States Adopted Name |
Bronhall may be available in the countries listed below.
Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Bronhall in the following countries:
International Drug Name Search
Belox may be available in the countries listed below.
Flucloxacillin sodium salt (a derivative of Flucloxacillin) is reported as an ingredient of Belox in the following countries:
International Drug Name Search
Pramiverina may be available in the countries listed below.
Pramiverina (DCIT) is also known as Pramiverine (Rec.INN)
International Drug Name Search
Glossary
| DCIT | Denominazione Comune Italiana |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Cetgel may be available in the countries listed below.
Cetirizine is reported as an ingredient of Cetgel in the following countries:
International Drug Name Search
Generic Name: dexmethylphenidate (dex METH il FEN i date)
Brand Names: Focalin, Focalin XR
Dexmethylphenidate is a mild stimulant to the central nervous system (brain and nerves).
Dexmethylphenidate is used to treat attention deficit hyperactivity disorder (ADHD).
Dexmethylphenidate may also be used for other purposes not listed in this medication guide.
Before using this medication, tell your doctor if you are allergic to any drugs, or if you have severe depression or a history of mental illness, seizures or epilepsy, high blood pressure, a history of drug or alcohol addiction, congestive heart failure, or if you have recently had a heart attack.
Long-term use of dexmethylphenidate can slow a child's growth. Tell your doctor if the child using this medication is not growing or gaining weight properly.
Keep track of how many pills have been used from each new bottle of this medicine. Dexmethylphenidate is a drug of abuse and you should be aware if any person in the household is using this medicine improperly or without a prescription.
glaucoma;
motor tics (twitches);
a personal or family history of Tourette's syndrome; or
if you have significant tension, agitation, or anxiety.
If you have any of these other conditions, you may need a dose adjustment or special tests to safely use dexmethylphenidate:
severe depression or a history of mental illness;
a history of drug or alcohol addiction;
seizures or epilepsy;
high blood pressure;
heart disease, heart rhythm problems, or congestive heart failure; or
if you have recently had a heart attack.
Long-term use of dexmethylphenidate can slow a child's growth. Tell your doctor if the child using this medication is not growing or gaining weight properly.
Keep track of how many pills have been used from each new bottle of this medicine. Dexmethylphenidate is a drug of abuse and you should be aware if any person in the household is using this medicine improperly or without a prescription.
Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label.
Your doctor may occasionally change your dose to make sure you get the best results from this medication.
This medication is usually taken in the morning before breakfast. You may take it with or without food.
You may open the dexmethylphenidate capsule and sprinkle the medicine into a spoonful of applesauce to make swallowing easier. Swallow this mixture right away without chewing. Do not save the mixture for later use. Discard the empty capsule.
To be sure this medication is helping your condition, your doctor will need to check your progress on a regular basis. Do not miss any scheduled visits to your doctor.
See also: Dexmethylphenidate dosage (in more detail)
Take the missed dose as soon as you remember. If it is almost time for your next dose, or if it is already evening, skip the missed dose and take the medicine the next morning. Taking this medicine late in the day can cause sleep problems. Do not take extra medicine to make up the missed dose.
Overdose symptoms may include dry mouth, sweating, headache, warmth or tingly feeling, vomiting, agitation, tremors, muscle twitches, confusion, hallucinations, fast or pounding heartbeats, large pupils, and seizure (convulsions).
Avoid taking dexmethylphenidate in the evening because it may cause sleep problems (insomnia).
dangerously high blood pressure (severe headache, blurred vision, ringing in your ears, chest pain, numbness, seizure);
fast or uneven heart rate;
blurred vision or other visual changes;
unusual behavior, confusion; or
twitching or tics.
Less serious side effects may include:
sleep problems (insomnia);
loss of appetite;
upset stomach;
feeling restless, anxious, or jittery;
dry mouth, sore throat; or
headache.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Attention Deficit Disorder:
Extended-release:
Patients currently not involved in treatment with dexmethylphenidate, racemic methylphenidate, or other stimulants:
Initial: 10 mg once a day (in the morning)
Maintenance: Dosage may be adjusted in 10 mg increments at approximately weekly intervals.
Maximum dose: 40 mg/day
Patients currently involved in treatment with methylphenidate:
Initial: one-half the total daily dose of racemic methylphenidate
Maximum dose: 40 mg/day
Patients currently taking dexmethylphenidate immediate-release:
Initial dose: dose equal to the daily dose of immediate-release administered once a day (in the morning).
Maximum dose: 40 mg/day
Usual Pediatric Dose for Attention Deficit Disorder:
Immediate-release:
6 to 18 years:
Patients not currently taking racemic methylphenidate or other stimulants:
Initial: 2.5 mg twice a day, with an interval of at least 4 hours between doses.
Maintenance: Dosage may be adjusted in 2.5 to 5 mg increments at approximately weekly intervals.
Maximum dose: 10 mg twice a day
Patients currently taking methylphenidate:
Initial: one-half the dose of racemic methylphenidate.
Maximum dose: 10 mg twice a day.
Extended-release:
6 to 18 years:
Patients not currently taking dexmethylphenidate, racemic methylphenidate, or other stimulants:
Initial: 5 mg once a day (in the morning)
Maintenance: Dosage may be adjusted in 5 mg increments at approximately weekly intervals.
Maximum dose: 30 mg per day
Patients currently taking methylphenidate:
Initial: one-half the dose of racemic methylphenidate.
Maximum dose: 30 mg per day
Patients currently taking dexmethylphenidate immediate-release:
Initial dose: dose equal to the daily dose of immediate-release administered once a day (in the morning).
Maximum dose: 30 mg per day
Before taking dexmethylphenidate, tell your doctor if you are using any of the following medicines:
antacids;
blood pressure medications;
a blood thinner such as warfarin (Coumadin);
clonidine (Catapres);
seizure medications such as phenytoin (Dilantin), phenobarbital (Luminal, Solfoton), primidone (Mysoline); or
antidepressants such as amitriptyline (Elavil, Etrafon), amoxapine (Ascendin), clomipramine (Anafranil), desipramine (Norpramin), imipramine (Janimine, Tofranil), nortriptyline (Pamelor), protriptyline (Vivactil), or trimipramine (Surmontil).
This list is not complete and there may be other drugs that can interact with dexmethylphenidate. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
See also: dexmethylphenidate side effects (in more detail)
